Angle plc is a specialist medical diagnostic company with products in cancer diagnostics and foetal health. The Company’s product is the Parsortix cell separation system, which can capture rare cells from blood. The resulting liquid biopsy (simple blood test) enables the investigation of mutations in the patient’s cancer for personalised cancer care. The system is based on a microfluidic device that captures cells based on a combination of their size and compressibility. The Parsortix system can handle blood volume of less than 1 milliliter and up to 50 milliliters enabling a range of applications. It can be used with all solid tumor cancers including breast, prostate, lung, and colorectal and is biomarker compatible.